Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Gild crawled time : 12:15 save search
Aadi Reports Third Quarter 2021 Financial Results and Provides Business Update
Published: 2021-11-10 (Crawled : 12:15) - globenewswire.com
AADI | $1.845 -2.9% -2.98% 84K
|
Manufacturing
|
| O: -4.13%
H: 0.0%
C: -16.65%
GILD | $67.03 0.12% 0.12% 5.2M
|
Health Technology
|
| O: 0.65%
H: 0.0%
C: 0.0%
financial results results
Jounce Therapeutics Progresses INNATE Study of JTX-8064 (LILRB2/ILT4 Inhibitor) Monotherapy and Pimivalimab (PD-1 Inhibitor) Combination Therapy in Patients with Advanced Solid Tumors
Published: 2021-10-07 (Crawled : 12:15) - globenewswire.com
JNCE | $1.88 -2.59% -1.85% 0
|
Health Technology
|
| O: 1.32%
H: 2.21%
C: 1.3%
GILD | $67.03 0.12% 0.12% 5.2M
|
Health Technology
|
| O: 0.03%
H: 1.21%
C: 0.95%
solid tumors therapy pimivalimab pd-1 inhibitor
Jounce Therapeutics Appoints Jigar Raythatha to its Board of Directors
Published: 2021-09-15 (Crawled : 12:15) - globenewswire.com
MOR | News | $18.04 0.45% 0.44% 180K
|
Health Technology
|
| O: -0.97%
H: 0.82%
C: 0.08%
JNCE | $1.88 -2.59% -1.85% 0
|
Health Technology
|
| O: 0.97%
H: 6.98%
C: 6.16%
GILD | $67.03 0.12% 0.12% 5.2M
|
Health Technology
|
| O: 0.18%
H: 2.7%
C: 1.67%
therapeutics
Aerovate Therapeutics Announces Second Quarter 2021 Financial Results
Published: 2021-08-16 (Crawled : 12:15) - globenewswire.com
AVTE M | $23.235 4.8% 4.58% 150K
|
Professional, Scientific, and T...
|
| O: -8.86%
H: 4.83%
C: 3.51%
PFE | News 4 | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: 1.54%
H: 1.53%
C: 1.41%
VYGR | News | $7.645 0.99% 0.98% 370K
|
Health Technology
|
| O: -3.31%
H: 2.05%
C: -1.37%
GILD | $67.03 0.12% 0.12% 5.2M
|
Health Technology
|
| O: 0.56%
H: 0.81%
C: 0.62%
financial results results therapeutics
BioNTech to Acquire Kite’s Neoantigen TCR Cell Therapy R&D Platform and Manufacturing Facility in Gaithersburg, MD
Published: 2021-07-19 (Crawled : 12:15) - globenewswire.com
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -0.68%
H: 0.41%
C: -0.31%
GILD | $67.03 0.12% 0.12% 5.2M
|
Health Technology
|
| O: 0.2%
H: 0.67%
C: -0.55%
BNTX | News | $88.53 0.59% 0.59% 360K
|
Health Technology
|
| O: 1.3%
H: 8.47%
C: 6.42%
therapy
Gilead to Present New Data at IAS 2021 Demonstrating the Company’s Commitment to Advancing Innovation in HIV Research
Published: 2021-07-12 (Crawled : 12:15) - biospace.com/
GILD | $67.03 0.12% 0.12% 5.2M
|
Health Technology
|
| O: 0.93%
H: 1.22%
C: -0.23%
research hiv
Jounce Therapeutics Provides Update on INNATE Study and Discovery Pipeline Expansion, and Provides a Portfolio Update at 2021 R&D Day
Published: 2021-06-23 (Crawled : 12:15) - globenewswire.com
JNCE | $1.88 -2.59% -1.85% 0
|
Health Technology
|
| O: 0.67%
H: 2.13%
C: -0.53%
GILD | $67.03 0.12% 0.12% 5.2M
|
Health Technology
|
| O: 0.24%
H: 0.06%
C: -0.83%
expansion
HOOKIPA to present Phase 1 safety, tolerability and preliminary anti-tumor activity data on HB-201 and HB-202 for the treatment of advanced HPV16+ cancers at ASCO
Published: 2021-05-20 (Crawled : 12:15) - biospace.com/
HOOK | $0.7801 10.34% 9.37% 790K
|
Health Technology
|
| O: -2.84%
H: 0.54%
C: -9.78%
GILD | $67.03 0.12% 0.12% 5.2M
|
Health Technology
|
| O: 0.23%
H: 1.92%
C: 1.0%
treatment phase 1 cancer phase 3 phase 2
Caribou Biosciences Announces Appointment of Industry Leader Andrew Guggenhime to its Board of Directors
Published: 2021-05-05 (Crawled : 12:15) - biospace.com/
WFC | $60.94 -0.26% 0.0% 22M
|
Finance
|
| O: 0.42%
H: 0.59%
C: 0.02%
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
|
| O: 0.24%
H: 2.61%
C: 2.21%
ABT | News | $107.59 0.49% -0.09% 3.8M
|
Health Technology
|
| O: 0.22%
H: 0.91%
C: 0.6%
PCVX | $60.89 -1.15% -1.17% 670K
|
Health Technology
|
| O: 3.85%
H: 1.81%
C: -0.7%
MTCR | $0.5814 -5.14% 84K
|
Health Technology
|
| O: 0.82%
H: 0.82%
C: -2.45%
GILD | $67.03 0.12% 0.12% 5.2M
|
Health Technology
|
| O: 0.15%
H: 1.92%
C: 1.17%
bioscience
Jounce Therapeutics to Present Trial in Progress Posters on the Phase 1 INNATE and the Phase 2 SELECT Clinical Trials at the 2021 American Society of Clinical Oncology (ASCO) Virtual Annual Meeting
Published: 2021-04-28 (Crawled : 12:15) - globenewswire.com
JNCE | $1.88 -2.59% -1.85% 0
|
Health Technology
|
| O: -0.3%
H: 0.3%
C: -3.8%
GILD | $67.03 0.12% 0.12% 5.2M
|
Health Technology
|
| O: 0.03%
H: 0.02%
C: -0.39%
phase 2 clinical trials phase 1 trial phase 3
Protara Therapeutics Announces Appointment of Martín Sebastian Olivo, M.D. as Chief Medical Officer
Published: 2021-04-19 (Crawled : 12:15) - globenewswire.com
TARA | $3.02 -0.98% -0.99% 410K
|
Health Technology
|
| O: -1.26%
H: 2.11%
C: -2.05%
GILD | $67.03 0.12% 0.12% 5.2M
|
Health Technology
|
| O: -0.25%
H: 0.45%
C: -1.12%
HOOKIPA Pharma to Present at Kempen Life Science Conference
Published: 2021-04-14 (Crawled : 12:15) - globenewswire.com
HOOK | $0.7801 10.34% 9.37% 790K
|
Health Technology
|
| O: 0.08%
H: 2.72%
C: 1.2%
GILD | $67.03 0.12% 0.12% 5.2M
|
Health Technology
|
| O: 0.12%
H: 1.85%
C: 0.51%
life science conference presentation pharma
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.